Gateway Blog

Gateway Blog

3-D Model of Heparanase, a Key Anti-Cancer Target, Developed

By Admin at 15 Feb 2016

Researchers from Griffith University's Institute for Glycomics have succeeded in a world first. They’ve used X-ray crystallography to create a 3-D image of a bacterial heparanase, a protein involved in cancer spread.

0 comments posted

    Categories

    Archive

    2018 2017 2016 2015
    99 cents of every dollar received directly funds cancer clinical trials

    58

    Current Gateway-funded clinical trials

    150+

    Clinical trials funded at leading institutions worldwide

    $16.56

    Funds one patient for one day at a Gateway-funded clinical trial

     
     

    Mission Partners